Metabolic Syndrome During Pregnancy: Prevalence and Determinants Among Pregnant Women Followed-Up at the Dschang District Hospital, West Region of Cameroon
- PMID: 35280500
- PMCID: PMC8906707
- DOI: 10.2147/DMSO.S348040
Metabolic Syndrome During Pregnancy: Prevalence and Determinants Among Pregnant Women Followed-Up at the Dschang District Hospital, West Region of Cameroon
Abstract
Purpose: Metabolic syndrome (MS) during pregnancy constitutes a serious threat to the mother and child health that will shortly become a major public health issue, especially in developing countries. However, in Cameroon, epidemiological data on MS during pregnancy are still scarce. The aim of this study was to determine the prevalence and determinants of MS among pregnant women followed-up at the Dschang District Hospital (DDH), in the west region of Cameroon.
Patients and methods: This study was a hospital based cross-sectional study, carried out among pregnant women followed-up at the antenatal care unit of the DDH, from September 2019 to June 2020. Participants were assessed on sociodemographic, lifestyle parameters, and dietary habits using standardized and structured questionnaires. Anthropometric parameters, blood pressure, and biochemical markers were measured using standard procedures. Metabolic syndrome was diagnosed using the HNLBI/AHA definition, modified for pregnant women by Chatzi et al. A participant was recorded as having MS if presenting at least three of the following criteria: Pre-gestational BMI >30 kg/m2; triglycerides ≥150 mg/dl; HDL cholesterol <50 mg/dl; SBP ≥130/DBP ≥85 mm/Hg; and fasting blood glucose ≥100 mg/dl.
Results: Six hundred and four (604) pregnant women were included in the study. The prevalence of MS was 17.88% (95% CI: 15.03-21.14) and its most frequent individual components were low levels of HDL-cholesterol (66.23% (95% CI: 62.36-69.88)) and hypertriglyceridemia (28% (95% CI: 54.31-62.15)). Grand multiparous shows a higher risk of presenting MS (OR:3.06, 95% CI: 1.24-7.12; p = 0.011) compared to nulliparous. Pregestational BMI appears to be the best predictor of MS during pregnancy even after adjustment on age, parity, lifestyle and dietary habits (OR: 46.46, 95% CI: 15.58-138.49; p ˂ 0.0001).
Conclusion: The prevalence of MS on pregnant women in the Dschang health district is 17.88% (95% CI: 15.03-21.14) and its major determinant is pre-gestational obesity. This work provides quality preliminary data for the design and improvement of prevention strategies.
Keywords: Dschang health district; metabolic syndrome; pregnancy; risk factors.
© 2022 Dabou et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
Assessing implementation modalities of mhealth intervention on pregnant women in Dschang health district, West region of Cameroon.Pan Afr Med J. 2019 Aug 19;33:305. doi: 10.11604/pamj.2019.33.305.17603. eCollection 2019. Pan Afr Med J. 2019. PMID: 31723372 Free PMC article.
-
Nutrition Habits and Health Outcomes of Breastfeeding HIV-positive mothers in the Dschang Health District, West Region Cameroon.Ig Sanita Pubbl. 2016 Sep-Oct;72(5):417-427. Ig Sanita Pubbl. 2016. PMID: 28068675
-
Group B Streptococcus colonisation, prevalence, associated risk factors and antimicrobial susceptibility pattern among pregnant women attending antenatal care at Dschang District Hospital, West Region of Cameroon: A hospital-based cross-sectional study.Int J Clin Pract. 2021 Oct;75(10):e14683. doi: 10.1111/ijcp.14683. Epub 2021 Aug 10. Int J Clin Pract. 2021. PMID: 34331733
-
[Evaluation of the diagnostic criteria of gestational metabolic syndrome and analysis of the risk factors].Zhonghua Fu Chan Ke Za Zhi. 2013 Feb;48(2):92-7. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 23544488 Chinese.
-
Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.Dan Med J. 2014 Jul;61(7):B4893. Dan Med J. 2014. PMID: 25123127 Review.
Cited by
-
Evaluation of the Effect of Supragingival Scaling on Periodontal Parameters in Pregnant Women with Metabolic Syndrome.J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S3925-S3931. doi: 10.4103/jpbs.jpbs_1372_24. Epub 2024 Dec 10. J Pharm Bioallied Sci. 2024. PMID: 39927038 Free PMC article.
-
Assessment of the Periodontal Parameters in Pregnant Women Diagnosed with Metabolic Syndrome: A Cross-Sectional Study.J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S3918-S3924. doi: 10.4103/jpbs.jpbs_1373_24. Epub 2024 Dec 10. J Pharm Bioallied Sci. 2024. PMID: 39926797 Free PMC article.
-
Prevalence of metabolic syndrome among pregnant women: a systematic review and meta-analysis.Endocrine. 2025 May;88(2):398-409. doi: 10.1007/s12020-025-04160-8. Epub 2025 Jan 22. Endocrine. 2025. PMID: 39841354 Free PMC article.
-
Prevalence and associated factors of metabolic syndrome among pregnant Ethiopian women: a hospital-based cross-sectional study.Sci Rep. 2024 Jun 23;14(1):14424. doi: 10.1038/s41598-024-65107-z. Sci Rep. 2024. PMID: 38909078 Free PMC article.
-
Prevalence of Metabolic Syndrome and Its Determinants in Pregnant Women in Auchi, Edo State, Nigeria.Rwanda J Med Health Sci. 2024 Nov 30;7(3):485-494. doi: 10.4314/rjmhs.v7i3.9. eCollection 2024 Nov. Rwanda J Med Health Sci. 2024. PMID: 40567461 Free PMC article.
References
-
- Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation taskforce on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circ. 2009;120:1640–1645. - PubMed
-
- Bo L, Guanqun C, Ruijie Z, Huang D, Tao L, Dan H and Lixin T. Temporal trends in the prevalence of metabolic syndrome among middle-aged and elderly adults from 2011 to 2015 in China: the China health and retirement longitudinal study (CHARLS). BMC Public Health. 2021;21:1045. doi:10.1186/s12889-021-11042-x - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials